Company News
Datar Cancer Genetics FDA Clears CellDx‑Tissue
Datar Cancer Genetics announced US FDA clearance for its CellDx‑Tissue assay, a dual‑DNA/RNA genomic profiling test for solid tumors.
The assay evaluates 517 cancer‑associated genes, detecting SNVs, i
